OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

BioCryst Pharmaceuticals/  US09058V1035  /

IEX
9/19/2024  9:59:55 PM Chg. +0.19 Volume Bid9:59:59 PM Ask9:59:59 PM High Low
8.16USD +2.38% 74,521
Turnover: 608,728.84		 8.15Bid Size: 200 8.16Ask Size: 538 8.30 8.03
GlobeNewswire 8/22 BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire 8/6 Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antivi...
GlobeNewswire 8/5 BioCryst Reports Second Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 8/2 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 7/22 BioCryst to Report Second Quarter 2024 Financial Results on August 5
GlobeNewswire 7/9 ORLADEYO® (berotralstat) Approved in Peru
GlobeNewswire 7/2 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 6/4 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 6/2 BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with No...
GlobeNewswire 5/16 Fortrea Appoints Machelle Sanders to Board of Directors
GlobeNewswire 5/14 BioCryst to Present New Data at 2024 Meeting of the European Academy of Allergy and Clinical Immunol...
GlobeNewswire 5/13 ORLADEYO® (berotralstat) Approved in Mexico
GlobeNewswire 5/9 Larimar Therapeutics Reports First Quarter 2024 Operating and Financial Results
GlobeNewswire 5/9 BioCryst Presents New Real-world Evidence Showing Significant Reductions in Healthcare Resource Util...
GlobeNewswire 5/7 BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire 5/6 BioCryst Reports First Quarter 2024 Financial Results and Provides Business Update
GlobeNewswire 5/3 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 4/22 BioCryst to Report First Quarter 2024 Financial Results on May 6
GlobeNewswire 4/17 BioCryst Announces Approval of ORLADEYO® (berotralstat) by the Brazilian Health Regulatory Agency
GlobeNewswire 4/3 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 3/25 BioCryst to Present at Upcoming Investor Conferences
GlobeNewswire 3/12 Clearside Biomedical Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corp...
GlobeNewswire 3/5 BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire 2/26 BioCryst Reports Fourth Quarter and Full Year 2023 Financial Results and Upcoming Key Milestones
GlobeNewswire 2/23 BioCryst Presents New Real-world Data Showing Rapid, Substantial and Sustained HAE Attack Rate Reduc...